Physician profile
Mark Grudman
NPI 1750330049
$11,601.28
in general payments reported to CMS, 2019-2025
50 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $1,098 · 2021: $974 · 2022: $1,836 · 2023: $2,347 · 2024: $2,187 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,021 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,021.30 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,137.96 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $970.74 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $938.38 | 2019-2025 | |
| Amgen INC. | $794.87 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $738.64 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $726.31 | 2019-2025 | |
| Abbott Laboratories | $724.67 | 2019-2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Abbvie INC. | $547.39 | 2022-2025 | |
| Pfizer INC. | $432.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $426.54 | 2021-2025 | Verquvo |
| Esperion Therapeutics, INC. | $341.78 | 2021-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $327.19 | 2019-2025 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $318.61 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $314.84 | 2019-2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $308.67 | 2019-2024 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $236.23 | 2019-2025 | Farxiga, Lokelma |
| Edwards Lifesciences Corporation | $216.85 | 2019-2023 | Sapien 3 Ultra Resilia |
| Regeneron Healthcare Solutions, INC. | $197.25 | 2019-2025 | Evkeeza |
| Siemens Medical Solutions USA, INC. | $169.88 | 2022-2023 | Acuson Redwood Diagnostic Ultrasound System |
| Lilly USA, LLC | $144.25 | 2019-2025 | Zepbound, Mounjaro |
| Lundbeck LLC | $126.84 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $113.12 | 2024 | Arcalyst |
| Chiesi USA, INC. | $112.90 | 2020-2024 | Cleviprex, Kengreal |
| Lexicon Pharmaceuticals, INC. | $109.10 | 2023-2024 | Inpefa |
| Medtronic, INC. | $104.60 | 2021-2023 | Azure Xt Dr Mri Surescan |
| Heartflow, INC. | $94.36 | 2022-2024 | |
| Arbor Pharmaceuticals, INC. | $92.21 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $87.32 | 2020-2022 | |
| Tactile Systems Technology INC | $84.18 | 2024 | Entre Plus, Flexitouch Plus |
| Cvrx, INC. | $81.46 | 2024-2025 | Barostim Neo System |
| Elutia, INC. | $57.85 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $55.44 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $47.17 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.46 | 2023-2024 | Lifevest |
| Althera Pharmaceuticals LLC | $38.53 | 2021 | |
| Vifor Pharma, INC. | $33.31 | 2019 | |
| Verona Pharma, INC. | $30.89 | 2025 | Ohtuvayre |
| Abiomed | $30.07 | 2025 | |
| Daiichi Sankyo INC. | $27.20 | 2023 | Injectafer |
| Baxter Healthcare | $26.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $26.43 | 2023 | Amvuttra |
| Medtronic Vascular, INC. | $25.09 | 2020 | |
| Bridgebio Pharma, INC. | $23.45 | 2025 | Attruby |
| Ionis Pharmaceuticals, INC. | $22.91 | 2025 | Tryngolza |
| Inspire Medical Systems, INC. | $22.80 | 2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $19.44 | 2025 | Terlivaz |
| Angiodynamics, INC. | $17.88 | 2023 | Auryon Laser System 100-120 Vac |
| Medicomp INC | $16.61 | 2025 | Telepatch Cardiac Monitor |
| Gilead Sciences, INC. | $13.52 | 2019 | |
| Bardy Diagnostics, INC. | $6.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grudman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.